Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivozanib in Advanced Renal Cell Carcinoma
NCT01297244Phase 2Completed
- Sponsor
- AVEO Oncology
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of tivozanib in renal cell carcinoma (RCC), sponsored by AVEO Oncology. Started Jan 2011; status: completed.
02
Drugs
tivozanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01297244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297244.